Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Moonshiner592on Nov 17, 2021 8:56pm
143 Views
Post# 34138893

RE:Stock price

RE:Stock price

Guys - Just wanted say that it’s not a party watching the stock-price at these levels .. some food for thought (copied and pasted from the Facebook site)

 

“I myself feel that the CEO should be busy running the company and start the Phase I as soon as POSSIBLE, instead of reaching out to insecure stockholders to hold hands and tell them everything will be fine. He doesn't have the time for it and definitely not the money to waste on it”

 

… why still hold shares in a company you do not feel right with? Sell, and buy stocks of the other companies who do webinars, interviews, etc. By the way, Bob will do all these things when he feels the company is doing fine, and that will be, in my opinion, very soon”

 

I agree with his last 2 words - we’re in Q4 - something is bound to pop - real soon!

 

More food for thought:  Could it be - that maybe whomever is alluding stuff is under NDA and cant come out and say things?? - 

 

Think about it .. 

 

GLTA

<< Previous
Bullboard Posts
Next >>